[NBIX] YoY Quarter Result on 31-Mar-2023 [#Q1]

Stock
[NBIX] Neurocrine Biosciences, Inc.
Announcement Date
03-May-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q1]
Profit Trend
QoQ- -186.07%
YoY- -651.08%
Quarter Report
NBIX's Result
NBIX's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
Revenue 515,300 420,400 310,600 236,600 237,100 138,403 71,086 39.07%
PBT 34,500 -103,300 21,400 27,200 38,900 -102,594 -41,818 -
Tax -8,900 -26,700 7,500 -4,900 1,500 -479 7,504 -
NP 43,400 -76,600 13,900 32,100 37,400 -102,115 -41,818 -
Tax Rate 25.80% - -35.05% 18.01% -3.86% - - -
Total Cost 471,900 497,000 296,700 204,500 199,700 240,518 112,904 26.89%
Ratio Analysis
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
NP Margin 8.42 -18.22 4.48 13.57 15.77 -73.78 -58.83 -
Per Share
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
EPS 0.43 -0.79 0.15 0.34 0.40 -1.12 -0.47 -
EPS Diluted 0.42 -0.79 0.14 0.33 0.39 -1.12 -0.47 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.